AR-A-008055

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAR-A-008055
Drug Alias Name(S)-(-)-AR-A 008055AR-A-008055
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsNerve DegenerationNeurotoxicity Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationNeurotoxicity Syndromes

Other Information

ATC CodeN/A
Related LinksN/A